| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.35 | 0.05 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.097 | 0.06 |